Wednesday, June 10, 2009
Biotechnology trade show Bangalore
The ninth edition of Bangalore Bio, organised by the State Department of Information Technology, Biotechnology, and Science and Technology, and the Vision Group on Biotechnology, will be held from June 18 to 20. The show will host 100 biotech speakers including Nobel Laureate Richard J. Roberts, who will deliver the key-note address.
Discussions will be held on process development and bio manufacturing, medical devices diagnostics and informatics, animal cell culture, development of vaccines, and industrial biotechnology among others. Bangalore Bio this year will see 120 exhibitors from the United Kingdom, Canada, Germany, France, Australia, South Africa, United States, Italy, Spain, Singapore and Japan. Kiran Majumdar-Shaw, Chairman and Managing Director of Biocon, which sponsors the annual biotechnology show, said, "Global research alliances and partnerships are critical to do research in a more cost affective, efficient and expedient way."
Meanwhile Shaw's company Biocon Limited got the BioSingapore Asia Pacific Biotechnology Award for "Best Listed Company" at the BioMedical Asia event held between 16 & 19 March 2009.
Kiran Mazumdar Shaw holds a vial of Basalog, a drug to control diabetes during its launch in Bangalore, India, Friday, May 29, 2009. Basalog, a long acting human insulin, will be available in 3 and 10 millimeter vials (photo: AP).
The product replaces other forms of insulin that do not act for a full 24 hours and require multiple injections. "The number of diabetics in the world, now 200 to 230 million, is expected to double by 2020. India alone may have 40 million diabetics and one out of every five diabetics in the world is likely to be of Indian origin by then," said Shaw at the launch.
Meanwhile Biocon's oral insulin drug IN-105 is in long-term human clinical trials.
Discussions will be held on process development and bio manufacturing, medical devices diagnostics and informatics, animal cell culture, development of vaccines, and industrial biotechnology among others. Bangalore Bio this year will see 120 exhibitors from the United Kingdom, Canada, Germany, France, Australia, South Africa, United States, Italy, Spain, Singapore and Japan. Kiran Majumdar-Shaw, Chairman and Managing Director of Biocon, which sponsors the annual biotechnology show, said, "Global research alliances and partnerships are critical to do research in a more cost affective, efficient and expedient way."
Meanwhile Shaw's company Biocon Limited got the BioSingapore Asia Pacific Biotechnology Award for "Best Listed Company" at the BioMedical Asia event held between 16 & 19 March 2009.
Biocon launches human insulin analogue Basalog
Kiran Mazumdar Shaw holds a vial of Basalog, a drug to control diabetes during its launch in Bangalore, India, Friday, May 29, 2009. Basalog, a long acting human insulin, will be available in 3 and 10 millimeter vials (photo: AP).
The product replaces other forms of insulin that do not act for a full 24 hours and require multiple injections. "The number of diabetics in the world, now 200 to 230 million, is expected to double by 2020. India alone may have 40 million diabetics and one out of every five diabetics in the world is likely to be of Indian origin by then," said Shaw at the launch.
Meanwhile Biocon's oral insulin drug IN-105 is in long-term human clinical trials.
